Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Anti-Congestive Heart Failure drugs >  Olprinone

Olprinone

Basic information Safety Supplier Related

Olprinone Basic information

Product Name:
Olprinone
Synonyms:
  • 1,2-dihydro-5-imidazo(1,2-alpha)pyridin-6-yl-6-methyl-2-oxonicotinonitrile
  • 5-(1,7-diazabicyclo[4.3.0]nona-2,4,6,8-tetraen-3-yl)-6-methyl-2-oxo-1h-pyridine-3-carbonitrile
  • OLPRINONE
  • 5-(Imidazo[1,2-a]pyridine-6-yl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile
  • Olprinone [inn]
  • 3-phenylmethoxy-1-cyclobutanecarboxylic acid ethyl ester
  • 1,2-Dihydro-5-(imidazo[1,2-a]pyridin-6-yl)-6-methyl-2-oxo-3-pyridinecarbonitrile
  • 3-Pyridinecarbonitrile,1,2-dihydro-5-imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-
CAS:
106730-54-5
MF:
C14H10N4O
MW:
250.26
Product Categories:
  • API
Mol File:
106730-54-5.mol
More
Less

Olprinone Chemical Properties

Melting point:
>300°
Density 
1.34±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Store in freezer, under -20°C
solubility 
DMSO
form 
Powder
pka
6.59±0.10(Predicted)
color 
White to off-white
InChI
InChI=1S/C14H10N4O/c1-9-12(6-11(7-15)14(19)17-9)10-2-3-13-16-4-5-18(13)8-10/h2-6,8H,1H3,(H,17,19)
InChIKey
JPAWFIIYTJQOKW-UHFFFAOYSA-N
SMILES
C1(=O)NC(C)=C(C2=CN3C=CN=C3C=C2)C=C1C#N
CAS DataBase Reference
106730-54-5(CAS DataBase Reference)
More
Less

Olprinone Usage And Synthesis

Description

Oprinone is an injection developed by Japan Co., Ltd. for the treatment of acute heart failure. It is a specific PDEⅢ inhibitor that selectively blocks cAMP and has high selectivity for the inhibition of human cardiac PDEⅢ.

Uses

Olprinone is used in the treatment of acute myocardial insufficiency.

Definition

ChEBI: Olprinone is a member of bipyridines.

Side effects

1. In the treatment of heart failure, the main adverse reactions of opprinone are manifested in the circulatory system, including premature ventricular contraction, tachycardia, increased ventricular tachyarrhythmia, and increased heart rate. Electric monitoring;
2. As a vasodilator, patients with renal insufficiency should use it in low doses. Long-term oral administration may lead to increased long-term mortality due to large adverse reactions, so it is only used for a short period of time.

Synthesis

4-(Dimethylamino)-3-(pyrimido[1,2-α]pyridin-6-yl)-3-buten-2-one and cyanoacetamide in dimethylformamide at 80~ Heating at 90°C for 12h to obtain Operinone.

References

[1] Patent: CN106349246, 2017, A. Location in patent: Paragraph 0023; 0028; 0029

Olprinone Preparation Products And Raw materials

Raw materials

OlprinoneSupplier

LGM Pharma
Tel
1-(800)-881-8210
Email
inquiries@lgmpharma.com
Beijing FaMu RuiSi Pharmaceuticals Co.,Ltd
Tel
18901358086
Email
pharma_reese@126.com
China Langchem Inc.
Tel
0086-21-58956006
ZhengZhou HuaWen Chemical Co.Ltd
Tel
0370-2785118 17550508557
Email
675141927@qq.com
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Email
waley188@sohu.com